| Jennifer Leone Kim, MD | |
|
6565 N Charles St Ste 406, Towson, MD 21204-5803 | |
| (443) 849-2568 | |
| Not Available |
| Full Name | Jennifer Leone Kim |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 6565 N Charles St Ste 406, Towson, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891114781 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D0085701 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greater Baltimore Medical Center Inc | 1759276975 | 309 |
News Archive
In a preliminary study, researchers find that vitamin E may be effective in restoring sudden onset hearing loss of unknown origin (idiopathic sudden hearing loss). These findings suggest that further research may reveal the role of antioxidants in the prevention and restoration of hearing loss.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
Genetically engineered mice convinced scientists at the Salk Institute for Biological Studies that it was time to overhaul widely held beliefs about how a powerful tumor suppressor called p53 is controlled in cells. Their new model of p53 regulation has important implications for the development of anticancer drugs.
Evaristo "Risto" Grant counted down from 10 as his clients held their plank positions and shook with the effort. Michael Jackson's "Wanna Be Startin' Somethin'" blared in the background. Grant paced around his clients on their yoga mats, shouting words of encouragement.
A scientist at the University of Bristol has been awarded £1.3 million to unlock the secrets of miniscule algae cells that have the remarkable ability to produce silica - the fundamental constituent of glass. It is hoped the findings from the research could lead to the next generation of medical imaging tools.
› Verified 4 days ago
| Entity Name | Greater Baltimore Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891855763 PECOS PAC ID: 1759276975 Enrollment ID: O20040217000852 |
News Archive
In a preliminary study, researchers find that vitamin E may be effective in restoring sudden onset hearing loss of unknown origin (idiopathic sudden hearing loss). These findings suggest that further research may reveal the role of antioxidants in the prevention and restoration of hearing loss.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
Genetically engineered mice convinced scientists at the Salk Institute for Biological Studies that it was time to overhaul widely held beliefs about how a powerful tumor suppressor called p53 is controlled in cells. Their new model of p53 regulation has important implications for the development of anticancer drugs.
Evaristo "Risto" Grant counted down from 10 as his clients held their plank positions and shook with the effort. Michael Jackson's "Wanna Be Startin' Somethin'" blared in the background. Grant paced around his clients on their yoga mats, shouting words of encouragement.
A scientist at the University of Bristol has been awarded £1.3 million to unlock the secrets of miniscule algae cells that have the remarkable ability to produce silica - the fundamental constituent of glass. It is hoped the findings from the research could lead to the next generation of medical imaging tools.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Leone Kim, MD 3976 E Lake Rd, Canandaigua, NY 14424-9779 Ph: (570) 362-0421 | Jennifer Leone Kim, MD 6565 N Charles St Ste 406, Towson, MD 21204-5803 Ph: (443) 849-2568 |
News Archive
In a preliminary study, researchers find that vitamin E may be effective in restoring sudden onset hearing loss of unknown origin (idiopathic sudden hearing loss). These findings suggest that further research may reveal the role of antioxidants in the prevention and restoration of hearing loss.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
Genetically engineered mice convinced scientists at the Salk Institute for Biological Studies that it was time to overhaul widely held beliefs about how a powerful tumor suppressor called p53 is controlled in cells. Their new model of p53 regulation has important implications for the development of anticancer drugs.
Evaristo "Risto" Grant counted down from 10 as his clients held their plank positions and shook with the effort. Michael Jackson's "Wanna Be Startin' Somethin'" blared in the background. Grant paced around his clients on their yoga mats, shouting words of encouragement.
A scientist at the University of Bristol has been awarded £1.3 million to unlock the secrets of miniscule algae cells that have the remarkable ability to produce silica - the fundamental constituent of glass. It is hoped the findings from the research could lead to the next generation of medical imaging tools.
› Verified 4 days ago
Thelma S Asare, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 West Rd, Suite 404, Towson, MD 21204 Phone: 410-832-5511 Fax: 410-832-5560 | |
Dr. Marwan Ahmad Hajj, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6569 N Charles Street, Suite 710, Towson, MD 21204 Phone: 410-321-1313 Fax: 410-321-1366 | |
Dr. Arthur William Nauman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 22 West Rd Ste 300, Towson, MD 21204 Phone: 410-321-6100 Fax: 443-275-2465 | |
Mary Anne Facciolo, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7801 York Rd, Ste 133, Towson, MD 21204 Phone: 410-339-7447 Fax: 410-339-3684 | |
Dr. Giles Harrison Manley, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6904 N Charles St, Towson, MD 21204 Phone: 410-916-6712 Fax: 410-653-3200 | |
Monica A Buescher, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7801 York Rd, Suite 133, Towson, MD 21204 Phone: 410-339-7447 Fax: 410-339-3684 | |
Dr. Andrea C Fitzgerald, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7401 Osler Dr, Suite 205, Towson, MD 21204 Phone: 410-828-8077 Fax: 410-828-8077 |